TY - JOUR
T1 - Prospective evaluation of patients with X-linked retinoschisis during 18 months
AU - XLRS-001 Study Group
AU - Pennesi, Mark E.
AU - Birch, David G.
AU - Jayasundera, K. Thiran
AU - Parker, Maria
AU - Tan, Ou
AU - Gurses-Ozden, Rabia
AU - Reichley, Carrie
AU - Beasley, Kathleen N.
AU - Yang, Paul
AU - Weleber, Richard G.
AU - Bennett, Lea D.
AU - Heckenlively, John R.
AU - Kothapalli, Kalyani
AU - Chulay, Jeffrey D.
N1 - Funding Information:
Supported in part by Grant TA-GT-0911-0559-AGTC-WG from the Foundation Fighting Blindness and in part by Applied Genetic Technologies Corporation (AGTC). Members of the XLRS-001 study group are listed in the Appendix. Investigators at Casey Eye Institute are supported by grant P30 EY010572 from the National Institutes of Health (Bethesda, MD, USA), and by unrestricted departmental funding from Research to Prevent Blindness (New York, NY, USA). KTJ is funded by NIH Grant K23 EY026985. LDB is supported by NIH Grant K99 EY027460. This study was registered at ClinicalTrials.gov (NCT02331173).
Publisher Copyright:
© 2018 The Authors.
PY - 2018/12
Y1 - 2018/12
N2 - PURPOSE. Prospective evaluation of patients with X-linked retinoschisis (XLRS). METHODS. Fifty-six males XLRS patients, age ≥7 years, had retinal structure and function tests performed every 6 months during an 18-month period. RESULTS. Best corrected visual acuity (BCVA) was abnormal (mean ± SD logMAR 0.57 ± 0.32 OD and 0.50 ± 0.27 OS), with weak correlation between visual acuity and age (R = 0.24, P = 0.0095). Mean cyst cavity volume (CCV) determined on optical coherence tomography showed weak correlation with age (R = 0.33, P = 0.0009) and no correlation with visual acuity. Subjects had modest reduction in mean kinetic and static perimetry results, reduced b-wave amplitude on electroretinography, abnormal reading speed results, and decreased visual function quality of life scores. Contrast sensitivity results were normal in 85 of 99 eyes tested. Most subjects had no meaningful change in BCVA during follow-up. Subjects who started carbonic anhydrase inhibitor (CAI) treatment at enrollment had improved BCVA (mean ± SD change 3.15 ± 7.8 ETDRS letters, with increase of ≥15 ETDRS letters at 8 of 110 visits [in 3 subjects]). There were no significant changes in other parameters tested. CONCLUSIONS. Structural and functional results were stable during the 18-month follow-up period. Some patients starting CAI treatment at the baseline visit showed improvement in BCVA that was not correlated with changes in CCV. Natural history data such as these will be important for comparisons to the changes in measures of retinal structure and function following gene replacement therapy in patients with XLRS.
AB - PURPOSE. Prospective evaluation of patients with X-linked retinoschisis (XLRS). METHODS. Fifty-six males XLRS patients, age ≥7 years, had retinal structure and function tests performed every 6 months during an 18-month period. RESULTS. Best corrected visual acuity (BCVA) was abnormal (mean ± SD logMAR 0.57 ± 0.32 OD and 0.50 ± 0.27 OS), with weak correlation between visual acuity and age (R = 0.24, P = 0.0095). Mean cyst cavity volume (CCV) determined on optical coherence tomography showed weak correlation with age (R = 0.33, P = 0.0009) and no correlation with visual acuity. Subjects had modest reduction in mean kinetic and static perimetry results, reduced b-wave amplitude on electroretinography, abnormal reading speed results, and decreased visual function quality of life scores. Contrast sensitivity results were normal in 85 of 99 eyes tested. Most subjects had no meaningful change in BCVA during follow-up. Subjects who started carbonic anhydrase inhibitor (CAI) treatment at enrollment had improved BCVA (mean ± SD change 3.15 ± 7.8 ETDRS letters, with increase of ≥15 ETDRS letters at 8 of 110 visits [in 3 subjects]). There were no significant changes in other parameters tested. CONCLUSIONS. Structural and functional results were stable during the 18-month follow-up period. Some patients starting CAI treatment at the baseline visit showed improvement in BCVA that was not correlated with changes in CCV. Natural history data such as these will be important for comparisons to the changes in measures of retinal structure and function following gene replacement therapy in patients with XLRS.
KW - Cyst cavity volume
KW - Retinoschisis
KW - XLRS
UR - http://www.scopus.com/inward/record.url?scp=85058925135&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85058925135&partnerID=8YFLogxK
U2 - 10.1167/iovs.18-24565
DO - 10.1167/iovs.18-24565
M3 - Article
C2 - 30551202
AN - SCOPUS:85058925135
SN - 0146-0404
VL - 59
SP - 5941
EP - 5956
JO - Investigative Ophthalmology and Visual Science
JF - Investigative Ophthalmology and Visual Science
IS - 15
ER -